Literature DB >> 3754344

Effects of ONO-6240, a platelet-activating factor antagonist, on endotoxin shock in unanesthetized sheep.

T Toyofuku, K Kubo, T Kobayashi, S Kusama.   

Abstract

To determine the role of platelet-activating factor (PAF) in endotoxin shock, we studied the effects of ONO-6240, a PAF antagonist, on endotoxin shock in unanesthetized sheep. Changes in hemodynamics, lung lymph balance, leukocyte and platelet counts, and arterial blood gas tensions were measured in four groups; endotoxin alone; endotoxin plus ONO-6240; ONO-6240 alone; vehicle control. Pretreatment with ONO-6240 in sheep given endotoxin significantly prevented the decreases in systemic arterial pressure, left atrial pressure and cardiac output observed in sheep given endotoxin alone. A partial effect on diminishing the magnitude of peripheral leukopenia was also noted. However, pretreatment with ONO-6240 had little effect on pulmonary hypertension and lung lymph balance. We conclude that endotoxin causes two different effects: vascular collapse and direct lung injury; and that PAF is involved only in the circulatory manifestations.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3754344     DOI: 10.1016/0090-6980(86)90053-5

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  5 in total

1.  Platelet-activating factor and hyperacute rejection. The effect of a platelet-activating factor antagonist, SRI 63-441, on rejection of xenografts and allografts in sensitized hosts.

Authors:  L Makowka; F A Chapman; D V Cramer; S G Qian; H Sun; T E Starzl
Journal:  Transplantation       Date:  1990-09       Impact factor: 4.939

2.  Effects of polycations on pulmonary vascular permeability in conscious sheep.

Authors:  T Toyofuku; S Koyama; T Kobayashi; S Kusama; G Ueda
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

Review 3.  Platelet-activating factor in cardiovascular stress situations.

Authors:  R Rabinovici; T L Yue; G Feuerstein
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

Review 4.  A Review on Platelet Activating Factor Inhibitors: Could a New Class of Potent Metal-Based Anti-Inflammatory Drugs Induce Anticancer Properties?

Authors:  Vasiliki D Papakonstantinou; Nefeli Lagopati; Effie C Tsilibary; Constantinos A Demopoulos; Athanassios I Philippopoulos
Journal:  Bioinorg Chem Appl       Date:  2017-03-28       Impact factor: 7.778

Review 5.  Forty Years Since the Structural Elucidation of Platelet-Activating Factor (PAF): Historical, Current, and Future Research Perspectives.

Authors:  Ronan Lordan; Alexandros Tsoupras; Ioannis Zabetakis; Constantinos A Demopoulos
Journal:  Molecules       Date:  2019-12-03       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.